Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvise Berti

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|July 2, 2019
The severe long-term outcomes of 'non-severe' eosinophilic granulomatosis with polyangiitisAlvise Berti
The New England Journal of Medicine|October 12, 2012
Distinct genetic subsets in ANCA-associated vasculitisAlvise Berti
European Journal of Internal Medicine|August 13, 2013
Painful fingersAlvise Berti, Corrado Campochiaro
The Journal of Rheumatology|July 8, 2021
The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated VasculitisAlvise Berti, Ulrich Specks
Rheumatology (Oxford, England)|July 20, 2019
Orbital masses in ANCA-associated vasculitis: an unsolved challenge?Alvise Berti, Andreas Kronbichler
Arthritis & Rheumatology (Hoboken, N.J.)|October 16, 2025
Interleukin (IL)-5, Eosinophils and IL-5 Pathway Inhibitors in Eosinophilic Granulomatosis with PolyangiitisAlvise Berti, Christian Pagnoux
Expert Review of Clinical Immunology|November 26, 2019
Remission maintenance in ANCA-associated vasculitis: does one size fit all?Alvise Berti, Ulrich Specks
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Update on the epidemiology, risk factors, and outcomes of systemic vasculitidesAlvise Berti, Christian Dejaco
Expert Opinion on Pharmacotherapy|May 19, 2023
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitisChristian Pagnoux, Alvise Berti
Mayo Clinic Proceedings|April 5, 2021
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 PneumoniaMarcello Cottini, Carlo Lombardi, Alvise Berti, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|July 2, 2019
The severe long-term outcomes of 'non-severe' eosinophilic granulomatosis with polyangiitisAlvise Berti
The New England Journal of Medicine|October 12, 2012
Distinct genetic subsets in ANCA-associated vasculitisAlvise Berti
European Journal of Internal Medicine|August 13, 2013
Painful fingersAlvise Berti, Corrado Campochiaro
The Journal of Rheumatology|July 8, 2021
The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated VasculitisAlvise Berti, Ulrich Specks
Rheumatology (Oxford, England)|July 20, 2019
Orbital masses in ANCA-associated vasculitis: an unsolved challenge?Alvise Berti, Andreas Kronbichler
Arthritis & Rheumatology (Hoboken, N.J.)|October 16, 2025
Interleukin (IL)-5, Eosinophils and IL-5 Pathway Inhibitors in Eosinophilic Granulomatosis with PolyangiitisAlvise Berti, Christian Pagnoux
Expert Review of Clinical Immunology|November 26, 2019
Remission maintenance in ANCA-associated vasculitis: does one size fit all?Alvise Berti, Ulrich Specks
Best Practice & Research. Clinical Rheumatology|December 12, 2018
Update on the epidemiology, risk factors, and outcomes of systemic vasculitidesAlvise Berti, Christian Dejaco
Expert Opinion on Pharmacotherapy|May 19, 2023
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitisChristian Pagnoux, Alvise Berti
Mayo Clinic Proceedings|April 5, 2021
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 PneumoniaMarcello Cottini, Carlo Lombardi, Alvise Berti, et al.
Pageof 12